Company / Debt per Share
Gilead Sciences Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$20.01
FY2025
5-year range
$20.01 / $21.44
FY2021-FY2025
Trend
-6.6%
vs FY2024
Sector context
#13 of 82
Health Care
What the data says
Gilead Sciences's debt per share of $20.01 is higher than 84% of companies in the Health Care sector (FY2025). Debt per Share has fluctuated over the past 10 years, ranging from $17.23 in FY2019 to $24.80 in FY2020.
Based on SEC 10-K filings.
20.01 in FY2025 with a 5-year CAGR of -4.2%. Top quartile in the Health Care sector.
Remained stable around $20.01 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 82This company $20.01 Sector average $151.59
▼
-86.8% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 6.6% year-over-year.
- Ranks #13 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2020.
- Lowest debt per share in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.01 | -6.6% |
| FY2024 | $21.44 | +7.0% |
| FY2023 | $20.04 | -0.4% |
| FY2022 | $20.12 | -5.5% |
| FY2021 | $21.29 | -14.2% |
| FY2020 | $24.80 | +43.9% |
| FY2019 | $17.23 | -8.3% |
| FY2018 | $18.79 | -20.1% |
| FY2017 | $23.51 | +26.9% |
| FY2016 | $18.53 | +25.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026